1 minute read
Consolidated statement of financial activities
FINANCIAL STATEMENTS
Consolidated statement of financial activities
Advertisement
INCLUDING AN INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2021
Income and endowments from:
Donations and legacies Charitable activities Other trading activities
Turnover of QS Enterprises Ltd
Other fundraising activities Investments Other
Total income
2021 2020 Unrestricted Restricted Endowment Total Total Funds Funds Funds Funds Funds Note £’000 £’000 £’000 £’000 £’000
3 7,539 265 – 7,804 9,774 819 – – 819 1,230
4 3,892 – – 3,892 5,706 37 – – 37 122 7 4,177 75 – 4,252 5,077 – – – – 29 16,464 340 – 16,804 21,938
Expenditure on:
Raising funds
Costs of generating donations and legacies 833 6 – 839 885
Fundraising trading expenditure Operating costs of QS Enterprises Ltd 4 4,509 – – 4,509 4,974 Operating costs of Middlesex Annexe LLP 6 9,311 – – 9,311 305 Other 24 – – 24 244
Investment management costs Costs of managing quoted investments 145 9 23 177 176 Costs of managing, maintaining and repairing investment properties 680 – – 680 1,258 Bank interest and charges on loan relating to investment properties 573 – – 573 226
Charitable activities 8 Medical equipment and infrastructure costs 7,488 4 – 7,492 2,825 Provision of staff and professional services 5,156 83 – 5,239 3,139 Patient welfare and amenities 1,878 1 – 1,879 2,038 Medical research 972 1 – 973 1,338 Staff education and development 2,200 2 – 2,202 5,261 Total expenditure 33,769 106 23 33,898 22,669 Net (expenditure)/income before investment gains (17,305) 234 (23) (17,094) (731) Net gains/(losses) on investments 15 2,280 302 1,088 3,670 (3,613) Net movements in funds (15,025) 536 1,065 (13,424) (4,344)
Reconciliation of funds
Total funds brought forward 20 147,493 3,053 6,845 157,391 161,735 Total funds carried forward 20 132,468 3,589 7,910 143,967 157,391
All of the group’s activities in the above two financial periods were derived from continuing operations. The notes on pages 33 to 51 form part of these accounts. Detailed comparative information for the year ended 31 March 2020 is given in note 1 to the accounts.
